- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Patent holdings for IPC class C07D 401/14
Total number of patents in this class: 18741
10-year publication summary
|
1214
|
1236
|
1220
|
1439
|
1475
|
1506
|
1499
|
1681
|
1447
|
809
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4878 |
441 |
| Novartis AG | 10847 |
357 |
| Boehringer Ingelheim International GmbH | 4656 |
342 |
| Merck Sharp & Dohme LLC | 3750 |
280 |
| Gilead Sciences, Inc. | 2037 |
266 |
| F. Hoffmann-La Roche AG | 7930 |
244 |
| Janssen Pharmaceutica N.V. | 3395 |
236 |
| Takeda Pharmaceutical Company Limited | 2714 |
228 |
| Merck Patent GmbH | 5830 |
209 |
| Pfizer Inc. | 3379 |
193 |
| Amgen Inc. | 4072 |
178 |
| Dana-Farber Cancer Institute, Inc. | 2567 |
175 |
| AstraZeneca AB | 2920 |
162 |
| Hoffmann-La Roche Inc. | 3414 |
150 |
| Genentech, Inc. | 3971 |
148 |
| Vertex Pharmaceuticals Incorporated | 1599 |
135 |
| Rigel Pharmaceuticals, Inc. | 539 |
125 |
| Syngenta Crop Protection AG | 6045 |
109 |
| LG Chem, Ltd. | 17620 |
106 |
| Celgene Corporation | 1400 |
100 |
| Other owners | 14557 |